MEN1 and gastrin-producing neuroendocrine tumor: In the study of patients with sporadic ZES, 25% had gastrinomas which demonstrated aggressive growth behavior during the study period [5], differing from patients with MEN1/ZES, with only 14% demonstrating aggressive growth during the study period [339].